Syntimmune syntimmune.com


Public lists: Pharma Startups (4732)

Syntimmune is a clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn).

Syntimmune is a clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn).

Company (Acquired)

Phone: 617-206-42220

Fax:

116 Huntington Ave
Suite 301
Boston, 02116
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Syntimmune $76M Sep 26, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Syntimmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)